Salarius Pharmaceuticals's Earnings: A Preview
Salarius Pharmaceuticals (NASDAQ:SLRX) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement.
Analysts estimate that Salarius Pharmaceuticals will report an earnings per share (EPS) of $-0.09.
Salarius Pharmaceuticals bulls will hope to hear the company to announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
Past Earnings Performance
Last quarter the company missed EPS by $0.01, which was followed by a 26.62% drop in the share price the next day.
Shares of Salarius Pharmaceuticals were trading at $0.1926 as of May 10. Over the last 52-week period, shares are down 84.27%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release.
This article was generated by Benzinga's automated content engine and reviewed by an editor.